Starting from this concept, the amounts of 5-HT in the bloodstream, along with the appraise of platelet 5-HT molecular targets such as platelet serotonin transporter (SERT), have been measured for years as indicators of the status, trait, and response to treatment of mood disorders (88–101). Here, SLC6A4 is linked to mood disorder.